PLEDGE NOW
Here and Now with Robin Young and Jeremy Hobson
Public radio's live
midday news program
With sponsorship from
Mathworks - Accelerating the pace of engineering and science
Accelerating the pace
of engineering and science
Thursday, August 7, 2014

Company Seeks Approval For Experimental Ebola Drug

In this handout from the Center for Disease Control (CDC), a colorized transmission electron micrograph (TEM) of a Ebola virus virion is seen. (Center for Disease Control via Getty Images)

In this handout from the Center for Disease Control (CDC), a colorized transmission electron micrograph (TEM) of a Ebola virus virion is seen. (Center for Disease Control via Getty Images)

There is no known cure for the Ebola virus, but a number of labs have been working on one. The two American relief workers recently flown back from Liberia have been receiving an experimental treatment produced by a company in San Diego.

Another company, Cambridge, Mass.-based Sarepta Therapeutics, also has an experimental drug. The company’s CEO, Chris Garabedian, tells Here & Now’s Robin Young how this treatment would work, and what it takes to get the drug to patients.

Guest


Please follow our community rules when engaging in comment discussion on this site.
Robin and Jeremy

Robin Young and Jeremy Hobson host Here & Now, a live two-hour production of NPR and WBUR Boston.

April 27 26 Comments

Economist: NAFTA Benefits Economy Despite Job Losses

Gordon Hanson explains his research on the effects of the North American Free Trade Agreement and why he still supports it.

April 27 12 Comments

HBO CEO Talks ‘Game Of Thrones’ And The Future Of Streaming

Richard Plepler discusses how the company is going after millennials and what he sees as the future of HBO and television.

April 26 4 Comments

How A City With 446 Bridges Deals With Infrastructure

Pittsburgh has more bridges than even Venice, Italy, but at least 20 are now labeled "structurally deficient."

April 26 2 Comments

Trump's State Chair Woos Unbound Delegates In Pennsylvania

The state has one of the most unique methods of assigning delegates. The GOP winner gets only 17 of 71 delegates.